Delivery Order SPE2DB22D9143-SPE2DB25FZB72

Award Date 4/2/25
Potential Completion Date 4/23/25
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGEML to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $16,441.36 and is a firm fixed-price delivery order with a period of performance ending on March 21, 2025. This award is part of a larger indefinite delivery contract (IDC) that DMS...
This federal contract award is for the delivery of STELARA 130 MG/26 ML VIAL 26ML to the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency. The award was made to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $3,730.56 and a completion date of October 7, 2024. It is not associated with a set-aside designation. DMS...
This federal contract award was issued by the Defense Logistics Agency (DLA), under its Medical Supply Chain division, to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $6,217.60 delivery order contract is for the supply of STELARA 130 MG/26 ML VIAL 26ML, a specialty pharmaceutical product. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA, under the SPE2DB program. This...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,435.20, is for the delivery of the pharmaceutical product STELARA 130 MG/26 ML VIAL 26ML. This order is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA, valued at up to $499,999,999, which allows the DLA to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,441.36 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML SYRINGEML, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables...
This federal contract award, valued at $16,441.36, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of Stelara 90 mg/mL syringes, a prescription medication. The contract is a delivery order under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999 and valid through November 2026. This IDC allows the DLA to issue...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $16,441.36 contract is for the provision of STELARA 90 MG/ML SYRINGEML, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,403.50 firm fixed-price delivery order is for the supply of 4558492360 - STELARA 130 MG/26 ML VIAL 26ML. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue delivery orders to DMS Pharmaceutical Group...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, with a ceiling value of $98,648.16, is for the delivery of Stelara 90 mg/ml syringes. The contract is a Firm Fixed Price Delivery Order with a period of performance through May 8, 2025. The contract does not have a set-aside designation. This award is part of a larger Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,212.00, is for the delivery of STELARA (ustekinumab) 130 mg/26 ml vials to support the recurring pharmaceutical needs of military health facilities. This delivery order is placed under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the...
  • SPE2DB22D9143
    Indefinite Delivery Contract
  • SPE2DB22D9143-SPE2DB25FZB72
    Delivery Order

This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGEML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $16,441.36 firm fixed-price contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, and does not have a set-aside designation. The contract is a delivery order under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, which enables the DLA to issue firm fixed-price orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. This contract award is for the delivery of the specialized medication STELARA to a location in Park Ridge, Illinois by the ultimate completion date of April 23, 2025.

Generated 7/2/25, 10:30 PM